Trial intelligence / Profile preview

Management of TBE Patients With Positive Anti-Lyme Antibodies

NCT02463942Unknown

Sponsor
University Medical Centre Ljubljana
Start
Sep 2014
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Trial of doxycycline in Lyme borreliosis (3 arms), sponsored by University Medical Centre Ljubljana. Primary endpoints: Objective manifestations of Lyme borreliosis at 1 year and Frequency of nonspecific symptoms such as headache, fatigue, arthralgia, myalgia at 1 year. Status: unknown.

02

Drugs

doxycycline
03

Conditions

Lyme borreliosis

Beyond the preview

Go deeper on NCT02463942.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02463942.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call